Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-15

FDA Approved: METHIMAZOLE — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved Upsher-Smith Laboratories' supplemental application for Methimazole (generic antithyroid drug), resulting in labeling changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methimazole (Methimazole)

Snippet

SUPPL AP for METHIMAZOLE (METHIMAZOLE)